These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
362 related articles for article (PubMed ID: 8105479)
1. Loss of retinoic acid receptor gamma function in F9 cells by gene disruption results in aberrant Hoxa-1 expression and differentiation upon retinoic acid treatment. Boylan JF; Lohnes D; Taneja R; Chambon P; Gudas LJ Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9601-5. PubMed ID: 8105479 [TBL] [Abstract][Full Text] [Related]
2. Targeted disruption of retinoic acid receptor alpha (RAR alpha) and RAR gamma results in receptor-specific alterations in retinoic acid-mediated differentiation and retinoic acid metabolism. Boylan JF; Lufkin T; Achkar CC; Taneja R; Chambon P; Gudas LJ Mol Cell Biol; 1995 Feb; 15(2):843-51. PubMed ID: 7823950 [TBL] [Abstract][Full Text] [Related]
3. Synergistic activation of retinoic acid (RA)-responsive genes and induction of embryonal carcinoma cell differentiation by an RA receptor alpha (RAR alpha)-, RAR beta-, or RAR gamma-selective ligand in combination with a retinoid X receptor-specific ligand. Roy B; Taneja R; Chambon P Mol Cell Biol; 1995 Dec; 15(12):6481-7. PubMed ID: 8524212 [TBL] [Abstract][Full Text] [Related]
4. Regulation of retinoid-induced differentiation in embryonal carcinoma PCC4.aza1R cells: effects of retinoid-receptor selective ligands. Mills KJ; Vollberg TM; Nervi C; Grippo JF; Dawson MI; Jetten AM Cell Growth Differ; 1996 Mar; 7(3):327-37. PubMed ID: 8838863 [TBL] [Abstract][Full Text] [Related]
5. Different response to retinoic acid of two teratocarcinoma cell lines. Wan YJ; Wang L; Wu TC Exp Cell Res; 1995 Aug; 219(2):392-8. PubMed ID: 7543852 [TBL] [Abstract][Full Text] [Related]
6. Reexpression of retinoic acid receptor (RAR) gamma or overexpression of RAR alpha or RAR beta in RAR gamma-null F9 cells reveals a partial functional redundancy between the three RAR types. Taneja R; Bouillet P; Boylan JF; Gaub MP; Roy B; Gudas LJ; Chambon P Proc Natl Acad Sci U S A; 1995 Aug; 92(17):7854-8. PubMed ID: 7644503 [TBL] [Abstract][Full Text] [Related]
7. Cell-type and promoter-context dependent retinoic acid receptor (RAR) redundancies for RAR beta 2 and Hoxa-1 activation in F9 and P19 cells can be artefactually generated by gene knockouts. Taneja R; Roy B; Plassat JL; Zusi CF; Ostrowski J; Reczek PR; Chambon P Proc Natl Acad Sci U S A; 1996 Jun; 93(12):6197-202. PubMed ID: 8650243 [TBL] [Abstract][Full Text] [Related]
8. Analysis of the factors involved in the retinoic acid-induced differentiation of a retinoid-hypersensitive embryonal carcinoma cell mutant. Dietrich JM; McCormick PJ Exp Cell Res; 1994 Feb; 210(2):201-8. PubMed ID: 8299717 [TBL] [Abstract][Full Text] [Related]
9. Murine endodermal F9E cells, derived from the teratocarcinoma line F9, contain high basal levels of retinoic acid receptors (RARs and RXRs) but are not sensitive to the actions of retinoic acid. Wan YJ; Wang L; Wu TC Differentiation; 1996 Jul; 60(4):211-8. PubMed ID: 8765051 [TBL] [Abstract][Full Text] [Related]
10. Retinoic acid differentially regulates retinoic acid receptor-mediated pathways in the Hep3B cell line. Wan YJ; Cai Y; Magee TR Exp Cell Res; 1998 Jan; 238(1):241-7. PubMed ID: 9457077 [TBL] [Abstract][Full Text] [Related]
11. Distinct retinoid X receptor-retinoic acid receptor heterodimers are differentially involved in the control of expression of retinoid target genes in F9 embryonal carcinoma cells. Chiba H; Clifford J; Metzger D; Chambon P Mol Cell Biol; 1997 Jun; 17(6):3013-20. PubMed ID: 9154799 [TBL] [Abstract][Full Text] [Related]
12. Increased expression of c-jun, but not retinoic acid receptor beta, is associated with F9 teratocarcinoma stem cell differentiation induced by polyamine depletion. Bjersing JL; Brorsson A; Heby O J Cell Biochem; 1997 Dec; 67(3):378-85. PubMed ID: 9361192 [TBL] [Abstract][Full Text] [Related]
13. F9 embryocarcinoma cells: a cell autonomous model to study the functional selectivity of RARs and RXRs in retinoid signaling. Rochette-Egly C; Chambon P Histol Histopathol; 2001 Jul; 16(3):909-22. PubMed ID: 11510982 [TBL] [Abstract][Full Text] [Related]
14. Down-regulation of retinoic acid receptor activity associated with decreased alpha and gamma isoforms expression in F9 embryonal carcinoma cells differentiated by retinoic acid. Lazega D; Schenker E; Busso N; Zelent A; Chen A; Waxman S J Cell Physiol; 1993 Oct; 157(1):90-6. PubMed ID: 8408246 [TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling elucidates a specific role for RARgamma in the retinoic acid-induced differentiation of F9 teratocarcinoma stem cells. Su D; Gudas LJ Biochem Pharmacol; 2008 Mar; 75(5):1129-60. PubMed ID: 18164278 [TBL] [Abstract][Full Text] [Related]
16. Derivation and characterization of retinoid-resistant human embryonal carcinoma cells. Moasser MM; Khoo KS; Maerz WJ; Zelenetz A; Dmitrovsky E Differentiation; 1996 Jul; 60(4):251-7. PubMed ID: 8765055 [TBL] [Abstract][Full Text] [Related]
17. Expression and up-regulation of retinoic acid receptor-beta is associated with retinoid sensitivity and colony formation in esophageal cancer cell lines. Xu XC; Liu X; Tahara E; Lippman SM; Lotan R Cancer Res; 1999 May; 59(10):2477-83. PubMed ID: 10344761 [TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of activation functions AF-1 and AF-2 of RAR alpha and RAR gamma is indispensable for differentiation of F9 cells upon retinoic acid and cAMP treatment. Taneja R; Rochette-Egly C; Plassat JL; Penna L; Gaub MP; Chambon P EMBO J; 1997 Nov; 16(21):6452-65. PubMed ID: 9351827 [TBL] [Abstract][Full Text] [Related]